0891 Comparison of the safety and efficacy of botulinum toxin type-A and tizanidine in the treatment of cervical dystonia
- Book ID
- 123076004
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 128 KB
- Volume
- 238
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo
## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type Aβresistant (AR) and nonβAβresistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on longβterm therapy with repeated injection sessions and it
## Abstract Shortβterm studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few longβterm studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t